The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes
about
alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapyERCC1 and telomere status in breast tumours treated with neoadjuvant chemotherapy and their association with patient prognosisEmodin affects ERCC1 expression in breast cancer cells.ERCC1 intron 1 was associated with breast cancer risk.Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypesGemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis.Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China.Neoadjuvant treatments for triple-negative breast cancer (TNBC).Anti-tumour activity of 4-(4-fluorophenyl)amino-5,6,7-trimethoxyquinazoline against tumour cells in vitro.High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer.ERCC1 Expression in Metastatic Triple Negative Breast Cancer Patients Treated with Platinum-Based ChemotherapyFOXP3 expression is related to high Ki-67 index and poor prognosis in lymph node-positive breast cancer patients.Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer.Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.Clinicopathological study of non-palpable familial breast cancer detected by screening mammography and diagnosed as DCIS
P2860
Q33830446-ACA5A840-0ED7-475D-A8BE-1422C823489EQ35038441-6D20328B-559C-4BB3-908D-F256997A197DQ35916938-A3C64F85-0E5B-4957-BFB1-817B2AE5D415Q36175526-F781F7B1-70C4-4A1F-8C62-B3553C94499CQ36244040-0529578D-F6DD-43F4-96AC-6EE9F75F80B9Q36286297-B182A507-DA2A-464E-BF0E-4367585ECC5AQ37340513-4AF1F2B9-E52D-4DF5-B2D5-1E28CF9701FEQ37360356-5AEE3493-6B77-4F96-9AD9-A621A05E0008Q37738530-409E497F-792D-4D05-98EC-7188FA2CAEECQ38046580-454A9DBE-31E5-44B5-9DEF-8C1F885DB145Q39445104-C1EE9B7F-3137-40EE-A151-07F3431FB39AQ41297799-6A5B4942-2E3E-4837-938E-DF64A2376B3BQ42143934-9F49EFEB-1A38-4046-B067-0C8B46C10CC6Q47772387-AF337639-398E-4B0C-B1C8-921FEFFB5076Q51361643-DDF0EE4C-A991-4A3E-86D2-1440DE0609D3Q51744122-C0D67316-B8E6-4F66-91BD-4D265CE9C54BQ54220808-8442E22C-8607-4F06-B7C3-2F8CF63AB090Q57700816-31B5634D-2CE3-4570-BF39-60CAC66FD673
P2860
The expression of ERCC1, RRM1, and BRCA1 in breast cancer according to the immunohistochemical phenotypes
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@ast
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@en
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@nl
type
label
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@ast
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@en
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@nl
prefLabel
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@ast
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@en
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@nl
P2860
P1476
The expression of ERCC1, RRM1, ...... immunohistochemical phenotypes
@en
P2093
Dokyung Kim
Woohee Jung
P2860
P304
P356
10.3346/JKMS.2011.26.3.352
P50
P577
2011-02-25T00:00:00Z